HUMAN LONGEVITY, INC. (HLI) is the genomics-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. HLI’s business focus includes the Health Nucleus, a genomic-powered, clinical research center which uses whole genome sequencing analysis, advanced digital imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health.
Health Nucleus (HN) is the premier health intelligence platform utilizing HLI’s state-of-the-art approach. Using proprietary technology to identify actionable insights today, we empower you and your physician to take control of your health, maintain peak performance and proactively plan for a long, healthier life. The Health Nucleus evaluation provides an unprecedented quantitative health assessment designed to explore individual risks of cardiovascular disease, cancer, neurological disease, trauma and/or degradation and metabolic health status. HN is designed for individuals to assess their health status, take preventative and proactive actions to mitigate disease risk, increase their healthy lifespan and maximize peak performance.
“Health Nucleus services are performed as part of a research study aiming to create and maintain high quality integrated personalized health data to facilitate medical discoveries and clinical insights for improvement of human health and the practice of medicine.”